# Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

> **NCT07076706** · PHASE2 · COMPLETED · sponsor: **Beijing Dayspring Pharmaceutical Technology Co., Ltd** · enrollment: 110 (actual)

## Conditions studied

- Male Pattern of Hair Loss, Androgenic Alopecia
- Androgenetic Alopecia (AGA)

## Interventions

- **DRUG:** minoxidil + finasteride
- **DRUG:** minoxidil + finasteride
- **DRUG:** Placebo foam

## Key facts

- **NCT ID:** NCT07076706
- **Lead sponsor:** Beijing Dayspring Pharmaceutical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-05
- **Primary completion:** 2025-08-26
- **Final completion:** 2025-09-23
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076706, "Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07076706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*